Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Merck & Company Inc, Common Stock

MRK

NYQ

$127

+$0.12

(0.09%)

Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$321.69B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

886.25

Volume

This is the total number of shares traded during the most recent trading day.

7.08M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

7.27M

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

2.43%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.40

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$97.81 L

$133.1 H

$127

About Merck & Company Inc, Common Stock

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians, wholesalers, government entities, veterinarians, distributors, animal producers, farmers, and pet owners. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates, which include patritumab deruxtecan, ifinatamab deruxtecan, and raludotatug deruxtecan for the treatment of multiple solid tumors both as monotherapy and/or in combination with other treatments; and AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications. The company also has a collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time Frame	MRK	Sector	S&P500
1-Week Return	1.3%	1.75%	1.05%
1-Month Return	1.35%	-3.02%	-2.74%
3-Month Return	7.51%	1.93%	4.56%
6-Month Return	24.95%	11.24%	20.31%
1-Year Return	12.54%	6.02%	24.48%
3-Year Return	88.3%	19.75%	26.81%
5-Year Return	107.46%	76.04%	88.12%
10-Year Return	214.33%	186.26%	224.44%

Time Frame	MRK	Sector	S&P500
1-Week Return	96.11%	147.10%	72.40%
1-Month Return	17.72%	-31.14%	-28.68%
3-Month Return	34.14%	8.06%	19.82%
6-Month Return	57.09%	24.11%	45.49%
1-Year Return	12.54%	6.02%	24.48%
3-Year Return	23.49%	6.19%	8.24%
5-Year Return	15.71%	11.98%	13.47%
10-Year Return	12.13%	11.09%	12.49%

Financials

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Revenue	46.84B	47.99B	48.70B	59.28B	59.87B	[{"date":"2019-12-31","value":78.23,"profit":true},{"date":"2020-12-31","value":80.16,"profit":true},{"date":"2021-12-31","value":81.35,"profit":true},{"date":"2022-12-31","value":99.02,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue	14.11B	15.48B	13.63B	17.41B	15.98B	[{"date":"2019-12-31","value":81.05,"profit":true},{"date":"2020-12-31","value":88.94,"profit":true},{"date":"2021-12-31","value":78.26,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":91.76,"profit":true}]
Gross Profit	32.73B	32.51B	35.08B	41.87B	43.89B	[{"date":"2019-12-31","value":74.56,"profit":true},{"date":"2020-12-31","value":74.06,"profit":true},{"date":"2021-12-31","value":79.92,"profit":true},{"date":"2022-12-31","value":95.39,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin	69.87%	67.74%	72.02%	70.63%	73.31%	[{"date":"2019-12-31","value":95.3,"profit":true},{"date":"2020-12-31","value":92.39,"profit":true},{"date":"2021-12-31","value":98.24,"profit":true},{"date":"2022-12-31","value":96.34,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Operating Expenses	20.49B	24.03B	21.88B	23.59B	40.91B	[{"date":"2019-12-31","value":50.08,"profit":true},{"date":"2020-12-31","value":58.73,"profit":true},{"date":"2021-12-31","value":53.48,"profit":true},{"date":"2022-12-31","value":57.66,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	9.23B	5.44B	10.65B	14.71B	2.98B	[{"date":"2019-12-31","value":62.73,"profit":true},{"date":"2020-12-31","value":36.95,"profit":true},{"date":"2021-12-31","value":72.37,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":20.27,"profit":true}]
Total Non-Operating Income/Expense	1.62B	2.58B	2.46B	929.00M	(1.77B)	[{"date":"2019-12-31","value":62.64,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":95.35,"profit":true},{"date":"2022-12-31","value":35.97,"profit":true},{"date":"2023-12-31","value":-68.68,"profit":false}]
Pre-Tax Income	11.46B	8.79B	13.88B	16.44B	1.89B	[{"date":"2019-12-31","value":69.72,"profit":true},{"date":"2020-12-31","value":53.46,"profit":true},{"date":"2021-12-31","value":84.4,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":11.49,"profit":true}]
Income Taxes	1.69B	1.71B	1.52B	1.92B	1.51B	[{"date":"2019-12-31","value":87.96,"profit":true},{"date":"2020-12-31","value":89.1,"profit":true},{"date":"2021-12-31","value":79.3,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":78.83,"profit":true}]
Income After Taxes	9.78B	7.08B	12.36B	14.53B	377.00M	[{"date":"2019-12-31","value":67.31,"profit":true},{"date":"2020-12-31","value":48.75,"profit":true},{"date":"2021-12-31","value":85.08,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":2.6,"profit":true}]

Income From Continuous Operations	9.78B	7.08B	12.36B	14.53B	4.62B	[{"date":"2019-12-31","value":67.31,"profit":true},{"date":"2020-12-31","value":48.75,"profit":true},{"date":"2021-12-31","value":85.08,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":31.81,"profit":true}]
Income From Discontinued Operations	704.00M	704.00M	704.00M	-	-	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	9.84B	7.07B	13.05B	14.52B	365.00M	[{"date":"2019-12-31","value":67.79,"profit":true},{"date":"2020-12-31","value":48.67,"profit":true},{"date":"2021-12-31","value":89.88,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":2.51,"profit":true}]

EPS (Diluted)	5.19	5.93	6.26	7.48	1.50	[{"date":"2019-12-31","value":69.39,"profit":true},{"date":"2020-12-31","value":79.28,"profit":true},{"date":"2021-12-31","value":83.69,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":20.05,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Revenue	-	2.46%	1.48%	21.72%	0.99%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":11.34,"profit":true},{"date":"2021-12-31","value":6.81,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":4.57,"profit":true}]
Cost of Revenue	-	9.73%	(12.01%)	27.78%	(8.24%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":35.03,"profit":true},{"date":"2021-12-31","value":-43.22,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-29.65,"profit":false}]
Gross Profit	-	(0.67%)	7.90%	19.37%	4.83%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-3.45,"profit":false},{"date":"2021-12-31","value":40.8,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":24.93,"profit":true}]
Gross Margin	-	(3.06%)	6.33%	(1.93%)	3.80%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-48.31,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-30.54,"profit":false},{"date":"2023-12-31","value":60.03,"profit":true}]

Operating Expenses	-	17.27%	(8.94%)	7.82%	73.43%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":23.53,"profit":true},{"date":"2021-12-31","value":-12.17,"profit":false},{"date":"2022-12-31","value":10.65,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	-	(41.09%)	95.84%	38.17%	(79.73%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-42.87,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":39.83,"profit":true},{"date":"2023-12-31","value":-83.19,"profit":false}]
Total Non-Operating Income/Expense	-	59.64%	(4.65%)	(62.28%)	(290.96%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-7.79,"profit":false},{"date":"2022-12-31","value":-104.43,"profit":false},{"date":"2023-12-31","value":-487.84,"profit":false}]
Pre-Tax Income	-	(23.32%)	57.88%	18.48%	(88.51%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-40.29,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":31.93,"profit":true},{"date":"2023-12-31","value":-152.93,"profit":false}]
Income Taxes	-	1.30%	(11.00%)	26.10%	(21.17%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":5,"profit":true},{"date":"2021-12-31","value":-42.15,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-81.1,"profit":false}]
Income After Taxes	-	(27.56%)	74.50%	17.54%	(97.40%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-37,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":23.55,"profit":true},{"date":"2023-12-31","value":-130.75,"profit":false}]

Income From Continuous Operations	-	(27.56%)	74.50%	17.54%	(68.19%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-37,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":23.55,"profit":true},{"date":"2023-12-31","value":-91.53,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	(28.20%)	84.65%	11.27%	(97.49%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-33.32,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":13.31,"profit":true},{"date":"2023-12-31","value":-115.17,"profit":false}]

EPS (Diluted)	-	14.26%	5.56%	19.49%	(79.95%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":73.16,"profit":true},{"date":"2021-12-31","value":28.55,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-410.22,"profit":false}]

	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	TREND
Total Revenue	14.49B	15.04B	15.96B	14.63B	14.63B	[{"date":"2023-03-31","value":90.76,"profit":true},{"date":"2023-06-30","value":94.19,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":91.66,"profit":true},{"date":"2024-03-31","value":91.66,"profit":true}]
Cost of Revenue	3.93B	4.02B	4.26B	3.34B	3.34B	[{"date":"2023-03-31","value":92.07,"profit":true},{"date":"2023-06-30","value":94.37,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":78.33,"profit":true},{"date":"2024-03-31","value":78.33,"profit":true}]
Gross Profit	10.56B	11.01B	11.70B	11.29B	11.29B	[{"date":"2023-03-31","value":90.28,"profit":true},{"date":"2023-06-30","value":94.13,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":96.51,"profit":true},{"date":"2024-03-31","value":96.51,"profit":true}]
Gross Margin	72.90%	73.24%	73.29%	77.17%	77.17%	[{"date":"2023-03-31","value":94.47,"profit":true},{"date":"2023-06-30","value":94.9,"profit":true},{"date":"2023-09-30","value":94.97,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]

Operating Expenses	6.75B	16.02B	5.83B	11.59B	11.59B	[{"date":"2023-03-31","value":42.16,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":36.36,"profit":true},{"date":"2023-12-31","value":72.33,"profit":true},{"date":"2024-03-31","value":72.33,"profit":true}]
Operating Income	2.88B	(4.86B)	6.00B	(299.00M)	(299.00M)	[{"date":"2023-03-31","value":48.05,"profit":true},{"date":"2023-06-30","value":-81.04,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-4.98,"profit":false},{"date":"2024-03-31","value":-4.98,"profit":false}]
Total Non-Operating Income/Expense	638.00M	(491.00M)	(496.00M)	(1.99B)	-	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-76.96,"profit":false},{"date":"2023-09-30","value":-77.74,"profit":false},{"date":"2023-12-31","value":-311.44,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]
Pre-Tax Income	3.65B	(5.33B)	5.62B	(2.05B)	(2.05B)	[{"date":"2023-03-31","value":64.95,"profit":true},{"date":"2023-06-30","value":-94.93,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-36.41,"profit":false},{"date":"2024-03-31","value":-36.41,"profit":false}]
Income Taxes	825.00M	637.00M	870.00M	(821.00M)	(821.00M)	[{"date":"2023-03-31","value":94.83,"profit":true},{"date":"2023-06-30","value":73.22,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-94.37,"profit":false},{"date":"2024-03-31","value":-94.37,"profit":false}]
Income After Taxes	2.83B	(5.97B)	4.75B	(1.23B)	-	[{"date":"2023-03-31","value":59.47,"profit":true},{"date":"2023-06-30","value":-125.73,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-25.79,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]

Income From Continuous Operations	2.83B	(5.97B)	4.75B	(1.23B)	-	[{"date":"2023-03-31","value":59.47,"profit":true},{"date":"2023-06-30","value":-125.73,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-25.81,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Net Income	2.82B	(5.97B)	4.75B	(1.23B)	(1.23B)	[{"date":"2023-03-31","value":59.45,"profit":true},{"date":"2023-06-30","value":-125.92,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-25.84,"profit":false},{"date":"2024-03-31","value":-25.84,"profit":false}]

EPS (Diluted)	1.40	(2.06)	2.13	0.03	-	[{"date":"2023-03-31","value":65.73,"profit":true},{"date":"2023-06-30","value":-96.71,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":1.41,"profit":true},{"date":"2024-03-31","value":"-","profit":true}]

	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	TREND
Total Revenue	-	3.78%	6.17%	(8.34%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":61.35,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-135.34,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]
Cost of Revenue	-	2.50%	5.96%	(21.67%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":41.85,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-363.33,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]
Gross Profit	-	4.26%	6.24%	(3.49%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":68.29,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-55.9,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]
Gross Margin	-	0.46%	0.07%	5.30%	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":8.7,"profit":true},{"date":"2023-09-30","value":1.31,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":"-","profit":true}]

Operating Expenses	-	137.20%	(63.64%)	98.92%	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-46.38,"profit":false},{"date":"2023-12-31","value":72.1,"profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Operating Income	-	(268.67%)	(223.39%)	(104.98%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":null,"profit":false},{"date":"2023-09-30","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]
Total Non-Operating Income/Expense	-	(176.96%)	1.02%	300.60%	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-58.87,"profit":false},{"date":"2023-09-30","value":0.34,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Pre-Tax Income	-	(246.16%)	(205.34%)	(136.41%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":null,"profit":false},{"date":"2023-09-30","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]
Income Taxes	-	(22.79%)	36.58%	(194.37%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-62.3,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-531.38,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]
Income After Taxes	-	(311.40%)	(179.54%)	(125.79%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":null,"profit":false},{"date":"2023-09-30","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]

Income From Continuous Operations	-	(311.40%)	(179.54%)	(125.81%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":null,"profit":false},{"date":"2023-09-30","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Net Income	-	(311.80%)	(179.41%)	(125.84%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":null,"profit":false},{"date":"2023-09-30","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]

EPS (Diluted)	-	(247.14%)	(203.40%)	(98.59%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":null,"profit":false},{"date":"2023-09-30","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Assets
Current Assets	27.48B	27.76B	30.27B	35.72B	32.17B	[{"date":"2019-12-31","value":76.94,"profit":true},{"date":"2020-12-31","value":77.72,"profit":true},{"date":"2021-12-31","value":84.73,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":90.05,"profit":true}]
Non-current Assets	56.91B	63.82B	75.43B	73.44B	74.51B	[{"date":"2019-12-31","value":75.45,"profit":true},{"date":"2020-12-31","value":84.62,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.36,"profit":true},{"date":"2023-12-31","value":98.78,"profit":true}]
Total Assets	84.40B	91.59B	105.69B	109.16B	106.67B	[{"date":"2019-12-31","value":77.31,"profit":true},{"date":"2020-12-31","value":83.9,"profit":true},{"date":"2021-12-31","value":96.82,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":97.72,"profit":true}]

Total Liabilities
Current Liabilities	22.22B	27.33B	23.87B	24.24B	25.69B	[{"date":"2019-12-31","value":81.31,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":87.36,"profit":true},{"date":"2022-12-31","value":88.7,"profit":true},{"date":"2023-12-31","value":94.02,"profit":true}]
Non-current Liabilities	36.18B	38.86B	43.56B	38.86B	43.35B	[{"date":"2019-12-31","value":83.04,"profit":true},{"date":"2020-12-31","value":89.19,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":89.21,"profit":true},{"date":"2023-12-31","value":99.5,"profit":true}]
Total Liabilities	58.40B	66.18B	67.44B	63.10B	69.04B	[{"date":"2019-12-31","value":84.58,"profit":true},{"date":"2020-12-31","value":95.86,"profit":true},{"date":"2021-12-31","value":97.68,"profit":true},{"date":"2022-12-31","value":91.4,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	1.79B	1.79B	1.79B	1.79B	1.79B	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Retained Earnings	46.60B	47.36B	53.70B	61.08B	53.90B	[{"date":"2019-12-31","value":76.3,"profit":true},{"date":"2020-12-31","value":77.54,"profit":true},{"date":"2021-12-31","value":87.91,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":88.24,"profit":true}]
Other Stockholders' Equity	(16.29B)	(17.20B)	(12.87B)	(12.11B)	(12.94B)	[{"date":"2019-12-31","value":-1629000000000,"profit":false},{"date":"2020-12-31","value":-1719900000000,"profit":false},{"date":"2021-12-31","value":-1287100000000,"profit":false},{"date":"2022-12-31","value":-1211000000000,"profit":false},{"date":"2023-12-31","value":-1294100000000,"profit":false}]
Total Shareholders' equity	25.91B	25.32B	38.18B	45.99B	37.58B	[{"date":"2019-12-31","value":56.33,"profit":true},{"date":"2020-12-31","value":55.05,"profit":true},{"date":"2021-12-31","value":83.02,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":81.71,"profit":true}]

Total Liabilities & Shareholders Equity	84.30B	91.50B	105.62B	109.09B	106.62B	[{"date":"2019-12-31","value":77.28,"profit":true},{"date":"2020-12-31","value":83.87,"profit":true},{"date":"2021-12-31","value":96.82,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":97.73,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Assets
Current Assets	-	1.02%	9.01%	18.03%	(9.95%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":5.67,"profit":true},{"date":"2021-12-31","value":49.99,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-55.19,"profit":false}]
Non-current Assets	-	12.14%	18.18%	(2.64%)	1.46%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":66.78,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-14.51,"profit":false},{"date":"2023-12-31","value":8.01,"profit":true}]
Total Assets	-	8.52%	15.40%	3.28%	(2.28%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":55.32,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":21.29,"profit":true},{"date":"2023-12-31","value":-14.78,"profit":false}]

Total Liabilities
Current Liabilities	-	22.98%	(12.64%)	1.54%	6.00%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-55.01,"profit":false},{"date":"2022-12-31","value":6.69,"profit":true},{"date":"2023-12-31","value":26.12,"profit":true}]
Non-current Liabilities	-	7.41%	12.12%	(10.79%)	11.54%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":61.17,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-89.08,"profit":false},{"date":"2023-12-31","value":95.21,"profit":true}]
Total Liabilities	-	13.34%	1.89%	(6.43%)	9.41%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":14.2,"profit":true},{"date":"2022-12-31","value":-48.2,"profit":false},{"date":"2023-12-31","value":70.56,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	-	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	-	1.63%	13.37%	13.75%	(11.76%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":11.86,"profit":true},{"date":"2021-12-31","value":97.24,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-85.54,"profit":false}]
Other Stockholders' Equity	-	5.58%	(25.16%)	(5.91%)	6.86%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":81.32,"profit":true},{"date":"2021-12-31","value":-366.71,"profit":false},{"date":"2022-12-31","value":-86.16,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Total Shareholders' equity	-	(2.28%)	50.82%	20.45%	(18.29%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-4.48,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":40.23,"profit":true},{"date":"2023-12-31","value":-35.98,"profit":false}]

Total Liabilities & Shareholders Equity	-	8.54%	15.43%	3.29%	(2.27%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":55.33,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":21.3,"profit":true},{"date":"2023-12-31","value":-14.68,"profit":false}]

	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	TREND
Total Assets
Current Assets	33.40B	29.98B	31.95B	32.17B	32.17B	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":89.75,"profit":true},{"date":"2023-09-30","value":95.66,"profit":true},{"date":"2023-12-31","value":96.31,"profit":true},{"date":"2024-03-31","value":96.31,"profit":true}]
Non-current Assets	74.39B	74.49B	74.77B	74.51B	74.51B	[{"date":"2023-03-31","value":99.49,"profit":true},{"date":"2023-06-30","value":99.62,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":99.64,"profit":true},{"date":"2024-03-31","value":99.64,"profit":true}]
Total Assets	107.80B	104.47B	106.73B	106.67B	106.67B	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":96.91,"profit":true},{"date":"2023-09-30","value":99.01,"profit":true},{"date":"2023-12-31","value":98.96,"profit":true},{"date":"2024-03-31","value":98.96,"profit":true}]

Total Liabilities
Current Liabilities	23.13B	23.39B	23.09B	25.69B	25.69B	[{"date":"2023-03-31","value":90.02,"profit":true},{"date":"2023-06-30","value":91.05,"profit":true},{"date":"2023-09-30","value":89.88,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Non-current Liabilities	37.76B	42.33B	42.33B	43.35B	43.35B	[{"date":"2023-03-31","value":87.11,"profit":true},{"date":"2023-06-30","value":97.66,"profit":true},{"date":"2023-09-30","value":97.66,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Total Liabilities	60.89B	65.73B	65.43B	69.04B	69.04B	[{"date":"2023-03-31","value":88.2,"profit":true},{"date":"2023-06-30","value":95.2,"profit":true},{"date":"2023-09-30","value":94.77,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	1.79B	1.79B	1.79B	1.79B	1.79B	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Retained Earnings	62.04B	54.20B	57.08B	53.90B	53.90B	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":87.36,"profit":true},{"date":"2023-09-30","value":92.01,"profit":true},{"date":"2023-12-31","value":86.87,"profit":true},{"date":"2024-03-31","value":86.87,"profit":true}]
Other Stockholders' Equity	(12.11B)	(12.39B)	(12.71B)	(12.94B)	(12.94B)	[{"date":"2023-03-31","value":-1211000000000,"profit":false},{"date":"2023-06-30","value":-1239300000000,"profit":false},{"date":"2023-09-30","value":-1270800000000,"profit":false},{"date":"2023-12-31","value":-1294100000000,"profit":false},{"date":"2024-03-31","value":-1294100000000,"profit":false}]
Total Shareholders' equity	46.83B	38.69B	41.25B	37.58B	37.58B	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":82.62,"profit":true},{"date":"2023-09-30","value":88.07,"profit":true},{"date":"2023-12-31","value":80.24,"profit":true},{"date":"2024-03-31","value":80.24,"profit":true}]

Total Liabilities & Shareholders Equity	107.72B	104.42B	106.67B	106.62B	106.62B	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":96.93,"profit":true},{"date":"2023-09-30","value":99.02,"profit":true},{"date":"2023-12-31","value":98.98,"profit":true},{"date":"2024-03-31","value":98.98,"profit":true}]

	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	TREND
Total Assets
Current Assets	-	(10.25%)	6.60%	0.67%	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-155.48,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":10.15,"profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Non-current Assets	-	0.13%	0.38%	(0.36%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":34.92,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-94.31,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]
Total Assets	-	(3.09%)	2.16%	(0.05%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-142.8,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-2.25,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]

Total Liabilities
Current Liabilities	-	1.14%	(1.28%)	11.26%	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":10.1,"profit":true},{"date":"2023-09-30","value":-11.39,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Non-current Liabilities	-	12.11%	-	2.39%	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":19.76,"profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Total Liabilities	-	7.94%	(0.46%)	5.52%	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-5.75,"profit":false},{"date":"2023-12-31","value":69.53,"profit":true},{"date":"2024-03-31","value":"-","profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	-	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Retained Earnings	-	(12.64%)	5.32%	(5.58%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-237.52,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-104.92,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]
Other Stockholders' Equity	-	2.34%	2.54%	1.83%	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":91.94,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":72.13,"profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Total Shareholders' equity	-	(17.38%)	6.60%	(8.89%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-263.45,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-134.67,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]

Total Liabilities & Shareholders Equity	-	(3.07%)	2.16%	(0.05%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-142.19,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-2.26,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Operating Activities
Net Operating Cash Flow	13.44B	10.25B	14.11B	19.09B	13.01B	[{"date":"2019-12-31","value":70.38,"profit":true},{"date":"2020-12-31","value":53.69,"profit":true},{"date":"2021-12-31","value":73.89,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":68.11,"profit":true}]

Investing Activities
Net Investing Cash Flow	(2.63B)	(9.44B)	(16.55B)	(4.96B)	(14.08B)	[{"date":"2019-12-31","value":-262900000000,"profit":false},{"date":"2020-12-31","value":-944300000000,"profit":false},{"date":"2021-12-31","value":-1655500000000,"profit":false},{"date":"2022-12-31","value":-496000000000,"profit":false},{"date":"2023-12-31","value":-1408300000000,"profit":false}]

Financing Activities
Net Financing Cash Flow	(8.86B)	(2.83B)	2.59B	(9.12B)	(4.81B)	[{"date":"2019-12-31","value":-341.73,"profit":false},{"date":"2020-12-31","value":-109.22,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-351.68,"profit":false},{"date":"2023-12-31","value":-185.5,"profit":false}]

Net Change in Cash	1.97B	(1.77B)	14.00M	4.61B	(5.86B)	[{"date":"2019-12-31","value":42.71,"profit":true},{"date":"2020-12-31","value":-38.41,"profit":false},{"date":"2021-12-31","value":0.3,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-127.31,"profit":false}]

Free Cash Flow
Free Cash Flow	9.97B	5.57B	9.66B	14.71B	9.14B	[{"date":"2019-12-31","value":67.77,"profit":true},{"date":"2020-12-31","value":37.87,"profit":true},{"date":"2021-12-31","value":65.69,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":62.17,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Operating Activities
Net Operating Cash Flow	-	(23.71%)	37.61%	35.34%	(31.89%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-63.05,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":93.97,"profit":true},{"date":"2023-12-31","value":-84.79,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	259.19%	75.32%	(70.04%)	183.93%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":29.06,"profit":true},{"date":"2022-12-31","value":-27.02,"profit":false},{"date":"2023-12-31","value":70.97,"profit":true}]

Financing Activities
Net Financing Cash Flow	-	(68.04%)	(191.56%)	(451.68%)	(47.25%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Net Change in Cash	-	(189.93%)	(100.79%)	32800.00%	(227.31%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-0.58,"profit":false},{"date":"2021-12-31","value":-0.31,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-0.69,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(44.13%)	73.48%	52.23%	(37.83%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-60.05,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":71.08,"profit":true},{"date":"2023-12-31","value":-51.49,"profit":false}]

	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	TREND
Operating Activities
Net Operating Cash Flow	1.34B	3.70B	7.72B	246.00M	246.00M	[{"date":"2023-03-31","value":17.35,"profit":true},{"date":"2023-06-30","value":48,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":3.19,"profit":true},{"date":"2024-03-31","value":3.19,"profit":true}]

Investing Activities
Net Investing Cash Flow	(2.36B)	(11.44B)	(334.00M)	53.00M	-	[{"date":"2023-03-31","value":-4450.94,"profit":false},{"date":"2023-06-30","value":-21590.57,"profit":false},{"date":"2023-09-30","value":-630.19,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	(2.05B)	3.76B	(4.27B)	(2.25B)	(2.25B)	[{"date":"2023-03-31","value":-54.66,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-113.6,"profit":false},{"date":"2023-12-31","value":-59.74,"profit":false},{"date":"2024-03-31","value":-59.74,"profit":false}]

Net Change in Cash	(2.99B)	(4.07B)	2.96B	(1.74B)	(1.74B)	[{"date":"2023-03-31","value":-101.01,"profit":false},{"date":"2023-06-30","value":-137.77,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-58.67,"profit":false},{"date":"2024-03-31","value":-58.67,"profit":false}]

Free Cash Flow
Free Cash Flow	332.00M	2.74B	6.82B	(743.00M)	(743.00M)	[{"date":"2023-03-31","value":4.87,"profit":true},{"date":"2023-06-30","value":40.19,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-10.9,"profit":false},{"date":"2024-03-31","value":-10.9,"profit":false}]

	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	TREND
Operating Activities
Net Operating Cash Flow	-	176.62%	108.34%	(96.81%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":61.34,"profit":true},{"date":"2023-12-31","value":-54.81,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]

Investing Activities
Net Investing Cash Flow	-	385.08%	(97.08%)	(115.87%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-25.21,"profit":false},{"date":"2023-12-31","value":-30.09,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	(282.96%)	(213.60%)	(47.41%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":null,"profit":false},{"date":"2023-09-30","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]

Net Change in Cash	-	36.39%	(172.58%)	(158.67%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-474.24,"profit":false},{"date":"2023-12-31","value":-436.03,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]

Free Cash Flow
Free Cash Flow	-	725.00%	148.81%	(110.90%)	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":20.53,"profit":true},{"date":"2023-12-31","value":-15.3,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	MRK
Cash Ratio	0.28
Current Ratio	1.25
Quick Ratio	1.00

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	MRK
ROA (LTM)	2.64%
ROE (LTM)	0.90%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	MRK
Debt Ratio Lower is generally better. Negative is bad.	0.65
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.35
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is.	2.84

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	MRK
Trailing PE	906.29
Forward PE	14.68
P/S (TTM)	5.30
P/B	8.48
Price/FCF	NM
EV/R	5.76
EV/Ebitda	50.16
PEG	NM

News

Hanmi, Merck Collaborate To Evaluate BH3120 + Keytruda Combination In Metastatic Solid Tumors

KENILWORTH (NJ) (dpa-AFX) - Korea''s Hanmi Pharmaceutical said it has entered into a Clinical Trial Collaboration and Supply Agreement with Merck & Co., Inc. (MRK).As per the agreement, Hanmi Pharm…

24 Apr, 2024 a 2:30 am Finanz Nachrichten

Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab)

Hanmi Pharmaceutical announces Clinical Trial Collaboration with MSD to evaluate ''BH3120'' in combination with KEYTRUDA in phase 1 clinical trial in patients with progressive or metastatic solid tumors SEOUL, South Korea , April 24, 2024 /PRNewswire/ -- Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park ), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and Supply Agreement (CTCSA) with MSD (a tradename of Merck & Co., Inc., Rahway, NJ , USA). Upon the execution of the agreement, Hanmi Pharmaceutical will conduct a phase 1 clinical trial to evaluate the safety and efficacy of its immuno-oncology drug, ''BH3120'', in combination with MSD''s anti-PD-1 therapy, KEYTRUDA ® (pembrolizumab), in patients with progressive or metastatic solid tumors. Hanmi Pharmaceutical will sponsor the clinical trial, and MSD will supply KEYTRUDA. ''BH3120'' is a next-generation immunotherapy drug that applies ''Pentambody'', a bispecific antibody platform technology, currently under joint development by Hanmi Pharmaceutical and its Chinese subsidiary, BJHM (Beijing Hanmi Pharmaceutical).

24 Apr, 2024 a 1:27 am PR Newswire Asia (English)

Investor Alert: Prepare for the Market Crash With These 3 Stocks

As an investor with significant positions in equities, I am an optimist. However, it’s important to be realistic at the same time. This helps in readjusting the portfolio depending on macroeconomic, geopolitical, and other headwinds. In my view, potential delay in rate cuts is likely to make the market nervous as it might imply a hard landing for the economy. I would therefore look at stocks to buy for a market crash. I must however add that I see the first-rate cut coming before the Presidential elections. Therefore, there are two strategies that I would consider for the coming quarters. First, buy low-beta blue-chip stocks that would protect the portfolio from capital erosion if there is a 10% to 15% correction in the index. Further, look at buying quality growth stocks if the broad markets indeed decline in the coming months. I expect a strong recovery in the markets towards the end of the year. For now, let’s discuss three stocks to buy for a market crash. Newmont Corporation (NEM) Source: Piotr Swat/Shutterstock Gold has declined from highs with tensions deescalating in the Middle East.

23 Apr, 2024 a 9:11 pm InvestorPlace

3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge

Big money tends to flow from one sector to the other. During the pandemic, sectors like pharmaceutical and e-commerce were hot. This was followed by major buying interest in electric vehicles and other energy transition themes. When money flows out from one sector, it generally translates into undervaluation. This seems to be the case with pharmaceutical stocks. During the covid-19 pandemic, the pharma sector witnessed big buying and valuations looked stretched. In the post pandemic world, the sector has been ignored. However, the pharmaceutical sector or the biotechnology sector bull story does not end with the pandemic. The lack of interest is a good opportunity to accumulate pharmaceutical stocks at a valuation gap for the next bull run. As unfortunate as it might sound, adverse health conditions continue to increase globally. This necessitates investment in new drugs and a big market for major pharmaceutical companies. The focus of this column is on pharma companies with a deep R&D pipeline that’s likely to translate into growth in the coming years.

23 Apr, 2024 a 7:00 pm InvestorPlace

Here’s Why Merck & Co. (MRK) Outperformed in Q1

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]

23 Apr, 2024 a 11:49 am Insider Monkey

Cramers week ahead: Earnings from Tesla, Merck and Big Tech

CNBC''sJim Cramersaid next week''s PCE index report will be the real gauge of inflation.

19 Apr, 2024 a 11:33 pm CNBC

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Merck & Company Inc share price today?

Merck & Company Inc (MRK) share price today is $127

Can Indians buy Merck & Company Inc shares?

Yes, Indians can buy shares of Merck & Company Inc (MRK) on Vested. To buy Merck & Company Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MRK stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Merck & Company Inc be purchased?

Yes, you can purchase fractional shares of Merck & Company Inc (MRK) via the Vested app. You can start investing in Merck & Company Inc (MRK) with a minimum investment of $1.

How to invest in Merck & Company Inc shares from India?

You can invest in shares of Merck & Company Inc (MRK) via Vested in three simple steps:

Click on Sign Up or Invest in MRK stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Merck & Company Inc shares

What is Merck & Company Inc 52-week high and low stock price?

The 52-week high price of Merck & Company Inc (MRK) is $133.1. The 52-week low price of Merck & Company Inc (MRK) is $97.81.

What is Merck & Company Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Merck & Company Inc (MRK) is 886.25

What is Merck & Company Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Merck & Company Inc (MRK) is 8.48

What is Merck & Company Inc dividend yield?

The dividend yield of Merck & Company Inc (MRK) is 2.43%

What is the Market Cap of Merck & Company Inc?

The market capitalization of Merck & Company Inc (MRK) is $321.69B

What is Merck & Company Inc’s stock symbol?

The stock symbol (or ticker) of Merck & Company Inc is MRK

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Global

India

Merck & Company Inc, Common Stock

MRK

NYQ

$127

+$0.12

(0.09%)

Analyst Forecast

Price Chart

Key Metrics

52-week Range This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

About Merck & Company Inc, Common Stock

Returns

Financials

Ratios

Liquidity

Asset Efficiency

Liabilities

Valuation

News

Hanmi, Merck Collaborate To Evaluate BH3120 + Keytruda Combination In Metastatic Solid Tumors

Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab)

Investor Alert: Prepare for the Market Crash With These 3 Stocks

3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge

Here’s Why Merck & Co. (MRK) Outperformed in Q1

Cramers week ahead: Earnings from Tesla, Merck and Big Tech

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

Feedback

Request to add more info/data

Inform about wrong info/data

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

Popular US Stocks ¹

Popular US ETFs ²